Biodesix, Inc. (NASDAQ:BDSX - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the five analysts that are covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, three have assigned a buy rating and one has assigned a s